Stocks · Health care · Biological Products, (No Diagnostic Substances)

BIOCRYST PHARMACEUTICALS INC

BCRX Clue Score70
United States Fiscal year ends December CIK 0000882796 Results filed 4 Nov 2026

What the insiders did Mostly scheduled

Insider
Date
Role
Action
Shares
Price
Amount
Jon P Stonehouse
2 Mar 2026
Director
Exercised, kept
305,995
$3.22
$985.30K
Charles K Gayer
22 Dec 2025
President and CCO
Exercised, kept
50,000
$5.51
$275.50K
Charles K Gayer
22 Dec 2025
President and CCO
Exercised, kept
10,091
$5.04
$50.86K
Charles K Gayer
22 Dec 2025
President and CCO
Exercised, kept
14,142
$3.22
$45.54K

What was left out

Form 4 filings counted 45
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 5
Sales straight out of an exercise 4
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 2,302,758
History held since 3 Nov 2006